Comparison of reconstruction methods used during liver transplantation in case of a graft with replaced or accessory right hepatic artery: A retrospective study.

graft anatomy hepatic artery thrombosis liver transplantation reconstruction method right hepatic artery

Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
Jun 2023
Historique:
revised: 13 09 2022
received: 26 04 2022
accepted: 04 10 2022
medline: 29 6 2023
pubmed: 16 11 2022
entrez: 15 11 2022
Statut: ppublish

Résumé

Variations in graft arterial anatomy can increase the risk of postoperative hepatic arterial thrombosis (HAT), especially in presence of a replaced or accessory right hepatic artery (RHA). We retrospectively analyzed 223 cases of liver transplantations with the presence of an RHA on the graft. Patient outcomes were compared according to the four different reconstruction methods used: (i) the re-implantation of the RHA into the splenic or gastroduodenal artery (n = 106); (ii) the interposition of the superior mesenteric artery (SMA) (n = 83); (iii) dual anastomosis (n = 24); (iv) use of an aortic patch including the origins of both the SMA and the coeliac trunk (n = 10). A competing risk analysis and Inverse Probability Weighting (IPW) were used. We found that the interposition of the SMA method was associated with a significantly lower incidence of HAT, at 4.8% compared to the re-implantation method at 17.9%, dual anastomosis at 12.5%, and aortic patch at 20%, p = .03. In the competing risk analysis with IPW, the only risk factor for RHA thrombosis was the type of reconstruction. Taking the SMA interposition group as the reference, the sub-hazard ratio (sHR) was 5.05 (CI 95 [1.72; 14.78], p < .01) for the re-implantation group, sHR = 2.37 (CI 95 [0.51; 11.09], p = .27) for the dual anastomosis group and sHR = 2.24 (CI 95 [0.35; 14.33], p = .40) for the aortic patch group. There were no differences for intraoperative transfusion, hospitalization duration (p = .37) or incidence of severe complications (p = .1). The long-term graft (p = .69) and patient (p = .52) survival was not different. In conclusion, the SMA interposition method was associated with a lower incidence of RHA thrombosis.

Identifiants

pubmed: 36377313
doi: 10.1002/jhbp.1268
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

843-850

Informations de copyright

© 2022 The Authors. Journal of Hepato-Biliary-Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Références

Duffy JP, Hong JC, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, et al. Vascular complications of orthotopic liver transplantation: experience in more than 4200 patients. J Am Coll Surg. 2009;208:896-903.
Tzakis AG, Gordon RD, Shaw BW, Iwatsuki S, Starzl TE. Clinical presentation of hepatic artery thrombosis after liver transplantation IN the cyclosporine era. Transplantation. 1985;40:667-71.
Mourad MM, Liossis C, Gunson BK, Mergental H, Isaac J, Muiesan P, et al. Etiology and management of hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2014;20:713-23.
Bekker J, Ploem S, Jong KPD. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9:746-57.
Stange B. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003;9:612-20.
Karakoyun R, Romano A, Yao M, Dlugosz R, Ericzon BG, Nowak G. Impact of hepatic artery variations and reconstructions on the outcome of orthotopic liver transplantation. World J Surg. 2020;44:1954-65.
Soliman T, Bodingbauer M, Langer F, Berlakovich GA, Wamser P, Rockenschaub S, et al. The role of complex hepatic artery reconstruction in orthotopic liver transplantation. Liver Transpl. 2003;9:970-5.
Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg. 1994;220:50-2.
Starzl TE. Experience in hepatic transplantation. Philadelphia: W. B. Saunders; 1969.
Andraus W, Haddad LBP, Ducatti L, Martino RB, Santos VR, D'Albuquerque LAC. Artery reconstruction in liver transplantation: the best reconstruction of right hepatic artery variation. Arq Bras Cir Dig. 2013;26:62-5.
Merhav HJ, Mieles LA, Ye Y, Selby RR, Snowden G. Alternative procedure for failed reconstruction of a right replaced hepatic artery in liver transplantation. Transpl Int. 1995;8:414-7.
Shaw BW Jr, Iwatsuki S, Starzl TE. Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet. 1984;159(5):490-3.
di Benedetto F, Cautero N, de Ruvo N, Masetti M, Montalti R, Gerunda GE, et al. A new reconstruction of the accessory donor right hepatic artery with interposition of the SMA in liver transplantation. Surgery. 2006;140:835.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45-9.
Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089-110.
Herrero A, Souche R, Joly E, Boisset G, Habibeh H, Bouyabrine H, et al. Early hepatic artery thrombosis after liver transplantation: what is the impact of the arterial reconstruction type? World J Surg. 2017;41:2101-10.
Oberkofler CE, Reese T, Raptis DA, Kuemmerli C, de Rougemont O, de Oliveira ML, et al. Hepatic artery occlusion in liver transplantation: what counts more, the type of reconstruction or the severity of the recipient's disease? Liver Transpl. 2018;24:790-802.
Oberkofler CE, Raptis DA, DiNorcia J, Kaldas FM, Müller PC, Pita A, et al. How to handle arterial conduits in liver transplantation? Evidence from the first multicenter risk analysis. Ann Surg. 2020;274:1032-42. https://doi.org/10.1097/SLA.0000000000003753
Beaurepaire JM, Orlando F, Levi Sandri GB, Jezequel C, Bardou-Jacquet E, Camus C, et al. Comparison of alternative arterial anastomosis site during liver transplantation when the recipient's hepatic artery is unusable. Hepatobiliary Surg Nutr. 2022;11:1-12.
Vasconcelos-Filho J-OM, Magalhães PRM, Monteiro BR, Moura AA, Silva GC, Fonseca-Neto OCL, et al. Frequency of anatomic variations on hepatic arteries and types of reconstruction employed: study on livers prepared for transplantation. Transplant Proc. 2020;52:1312-3.
Melada E, Maggi U, Rossi G, Caccamo L, Gatti S, Paone G, et al. Back-table arterial reconstructions in liver transplantation: single-center experience. Transplant Proc. 2005;37:2587-8.
Hevelke P, Grodzicki M, Nyckowski P, Zieniewicz K, Patkowski W, Alsharabi A, et al. Hepatic artery reconstruction prior to orthotopic liver transplantation. Transplant Proc. 2003;35:2253-5.
Tsaroucha A, Webb M, Karatzas T, Dickson P, Demirbas A, Fragulidis G, et al. Management of allograft-replaced right hepatic arteries in liver transplantation: a review of the university of Miami experience and a preferred method of reconstruction. Transplant Proc. 1997;29:2856-8.

Auteurs

Dune Wouters (D)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Marc Blondeau (M)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, Rennes, France.

Isabel Bos (I)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Christophe Camus (C)

CHU Rennes, Service de Maladies Infectieuses et Réanimation Médicale, Rennes, France.

Caroline Jezequel (C)

CHU Rennes, Service des maladies du foie, Rennes, France.

Edouard Bardou-Jacquet (E)

CHU Rennes, Service des maladies du foie, Rennes, France.
Univ Rennes, INSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer), Rennes, France.

Willemijn S van der Plas (WS)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Lianne M Nieuwenhuis (LM)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Vincent E de Meijer (VE)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Robert J Porte (RJ)

Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Michel Rayar (M)

CHU Rennes, Service de Chirurgie Hépatobiliaire et Digestive, Rennes, France.
Univ Rennes, INSERM, INRAE, Institut NUMECAN (Nutrition Metabolisms and Cancer), Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH